Clinical Trials · NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Lumos Pharma
- Enrollment
- 202
- Start date
- Feb 2027
- Locations
- See registry
- Primary endpoint
- Proportion of participants with Short Physical Performance Battery (SPPB) score ≤ 7 at Week 26.